Summary & Overview
CPT 0059U: Merkel Virus VP1 Capsid Antibody Test
CPT code 0059U is a Proprietary Laboratory Analyses (PLA) code for the Merkel Virus VP1 Capsid Antibody assay developed and performed by the University of Washington, Department of Laboratory Medicine. The test identifies antibodies to the polyomavirus capsid protein VP1; a positive finding signals exposure to Merkel cell polyomavirus, which has clinical relevance for epidemiologic assessment and adjunctive evaluation in suspected Merkel cell carcinoma cases, though it does not confirm malignancy. Nationally, PLA codes like 0059U matter because they track unique, manufacturer- or lab-specific diagnostics that are increasingly used in precision infectious disease and oncology testing.
Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find a concise overview of the code’s clinical purpose, the typical laboratory service setting, and payer coverage landscape. The publication outlines common modifiers associated with laboratory billing, clarifies the test’s diagnostic context and limitations, and summarizes what to expect in claims processing for a proprietary serologic assay. This resource is intended to inform billing staff, laboratory administrators, and policy analysts about the role of CPT code 0059U in clinical workflows and reimbursement discussions. Data not available in the input are noted where applicable.
Billing Code Overview
CPT code 0059U is a Proprietary Laboratory Analyses (PLA) code for the Merkel Virus VP1 Capsid Antibody test performed by the University of Washington, Department of Laboratory Medicine. The test detects antibodies to the polyomavirus capsid protein (VP1); a positive result indicates prior exposure to Merkel cell polyomavirus but does not establish a diagnosis of Merkel cell carcinoma, while a negative result indicates lack of exposure.
-
Service type: Laboratory serologic assay (proprietary antibody test)
-
Typical site of service: Clinical laboratory or reference laboratory (University of Washington Department of Laboratory Medicine)
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with a history of a rapidly growing, non-tender cutaneous nodule on sun-exposed skin is referred to dermatology for evaluation. The dermatologist performs a biopsy of the lesion; pathology is suspicious but not definitive for Merkel cell carcinoma (MCC). The dermatologist orders a serum or tissue-based Merkel cell polyomavirus (MCPyV) capsid protein VP1 antibody assay to assess prior exposure to Merkel cell polyomavirus, using the University of Washington Department of Laboratory Medicine test reported with CPT code 0059U. A positive 0059U result indicates prior exposure to MCPyV and may support clinical suspicion of MCC in the context of compatible histopathology; a negative result indicates lack of detectable exposure. Typical sites of service include outpatient dermatology clinics, hospital outpatient departments, and clinical laboratories where specimens (serum or tissue) are collected and shipped to the performing laboratory. The specimen is collected per laboratory instructions, sent to the designated laboratory, analyzed using the proprietary assay, and results are returned to the ordering clinician to inform diagnosis, staging considerations, or surveillance planning.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — default reporting | Use when no special circumstances apply to the laboratory service. |